Bonesupport lands CE Mark for next-gen antibiotic bone graft substitute

February 19, 2013 by MassDevice staff

Swedish orthopedic company Bonesupport touts European regulatory approval for its next-generation Cerament|G resorbable, antibiotic bone substitute.

Bonesupport logo

Swedish orthopedic trauma products maker Bonesupport won CE Mark approval in the European Union for its next-generation Cerament|G injectable antibiotic-eluting bone substitute.

The Cerament|G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months while preventing colonization of microorganisms, especially in cases of deep bone infection.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp